BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

672 related articles for article (PubMed ID: 8680047)

  • 1. Molecular mechanisms of new immunosuppressants.
    Halloran PF
    Clin Transplant; 1996 Feb; 10(1 Pt 2):118-23. PubMed ID: 8680047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New small molecule immunosuppressants for transplantation: review of essential concepts.
    Morris RE
    J Heart Lung Transplant; 1993; 12(6 Pt 2):S275-86. PubMed ID: 7508752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The immunosuppressive and toxic effects of FK-506 are mechanistically related: pharmacology of a novel antagonist of FK-506 and rapamycin.
    Dumont FJ; Staruch MJ; Koprak SL; Siekierka JJ; Lin CS; Harrison R; Sewell T; Kindt VM; Beattie TR; Wyvratt M
    J Exp Med; 1992 Sep; 176(3):751-60. PubMed ID: 1380976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roles of peptidyl-prolyl cis-trans isomerase and calcineurin in the mechanisms of antimalarial action of cyclosporin A, FK506, and rapamycin.
    Bell A; Wernli B; Franklin RM
    Biochem Pharmacol; 1994 Aug; 48(3):495-503. PubMed ID: 7520696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclosporin A, FK506 and rapamycin: more than just immunosuppression.
    Kunz J; Hall MN
    Trends Biochem Sci; 1993 Sep; 18(9):334-8. PubMed ID: 7694398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclosporin A, FK-506, and rapamycin: pharmacologic probes of lymphocyte signal transduction.
    Sigal NH; Dumont FJ
    Annu Rev Immunol; 1992; 10():519-60. PubMed ID: 1375473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purine metabolism and immunosuppressive effects of mycophenolate mofetil (MMF).
    Allison AC; Eugui EM
    Clin Transplant; 1996 Feb; 10(1 Pt 2):77-84. PubMed ID: 8680053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcineurin phosphatase activity in T lymphocytes is inhibited by FK 506 and cyclosporin A.
    Fruman DA; Klee CB; Bierer BE; Burakoff SJ
    Proc Natl Acad Sci U S A; 1992 May; 89(9):3686-90. PubMed ID: 1373887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of calcineurin by a novel FK-506-binding protein.
    Sewell TJ; Lam E; Martin MM; Leszyk J; Weidner J; Calaycay J; Griffin P; Williams H; Hung S; Cryan J
    J Biol Chem; 1994 Aug; 269(33):21094-102. PubMed ID: 7520438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunosuppressive drugs: the first 50 years and a glance forward.
    Allison AC
    Immunopharmacology; 2000 May; 47(2-3):63-83. PubMed ID: 10878284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FKBP51, a novel T-cell-specific immunophilin capable of calcineurin inhibition.
    Baughman G; Wiederrecht GJ; Campbell NF; Martin MM; Bourgeois S
    Mol Cell Biol; 1995 Aug; 15(8):4395-402. PubMed ID: 7542743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mycophenolic acid inhibits IL-2-dependent T cell proliferation, but not IL-2-dependent survival and sensitization to apoptosis.
    Quéméneur L; Flacher M; Gerland LM; Ffrench M; Revillard JP; Bonnefoy-Berard N
    J Immunol; 2002 Sep; 169(5):2747-55. PubMed ID: 12193749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacological profiles of mycophenolate mofetil (CellCept), a new immunosuppressive agent].
    Yashima Y; Ohgane T
    Nihon Yakurigaku Zasshi; 2001 Feb; 117(2):131-7. PubMed ID: 11233304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes.
    Liu J; Farmer JD; Lane WS; Friedman J; Weissman I; Schreiber SL
    Cell; 1991 Aug; 66(4):807-15. PubMed ID: 1715244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunosuppressive activity of [MeBm2t]1-, D-diaminobutyryl-8-, and D-diaminopropyl-8-cyclosporin analogues correlates with inhibition of calcineurin phosphatase activity.
    Nelson PA; Akselband Y; Kawamura A; Su M; Tung RD; Rich DH; Kishore V; Rosborough SL; DeCenzo MT; Livingston DJ
    J Immunol; 1993 Mar; 150(6):2139-47. PubMed ID: 7680683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sanglifehrin A, a novel cyclophilin-binding compound showing immunosuppressive activity with a new mechanism of action.
    Zenke G; Strittmatter U; Fuchs S; Quesniaux VF; Brinkmann V; Schuler W; Zurini M; Enz A; Billich A; Sanglier JJ; Fehr T
    J Immunol; 2001 Jun; 166(12):7165-71. PubMed ID: 11390463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular mechanisms of immunosuppression by cyclosporine, FK506, and rapamycin.
    Cardenas ME; Zhu D; Heitman J
    Curr Opin Nephrol Hypertens; 1995 Nov; 4(6):472-7. PubMed ID: 8591053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular analysis of the interaction of calcineurin with drug-immunophilin complexes.
    Clipstone NA; Fiorentino DF; Crabtree GR
    J Biol Chem; 1994 Oct; 269(42):26431-7. PubMed ID: 7523407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A role for calcineurin in degranulation of murine cytotoxic T lymphocytes.
    Dutz JP; Fruman DA; Burakoff SJ; Bierer BE
    J Immunol; 1993 Apr; 150(7):2591-8. PubMed ID: 7681074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclosporin A, FK506, and rapamycin: binding to immunophilins and biological action.
    Bierer BE
    Chem Immunol; 1994; 59():128-55. PubMed ID: 7524531
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 34.